Roic AI
Solutions
API Docs
MCP
Pricing
Discord
Resources
Toggle navigation menu
Company Search
⌘
K
Toggle theme
Toggle theme
Login
Sign up
United States Stocks
•
Health technology
•
Biotechnology
Halozyme Therapeutics, Inc.
B
BX:RV7
BX Swiss
101.90
CHF
+49.04
(+92.78%)
3.36
EPS
Feb 23
Next Earn
No stock splits recorded
Our records contain no stock splits for Halozyme Therapeutics, Inc. (BX:RV7).
Stock splits API
Summary
Financials
Ratios
Transcripts
Documents
Charts
Classic View
Statistics
Stock Splits